Microarrays & Multiplexing

News on microarrays, multiplexing, genotyping, cytogenetics, gene expression profiling in genetics, genomics, and molecular diagnostics.

Jun 8, 2022

LumiraDx Gets CE Marks for SARS-CoV-2 Test, COVID-19-Flu Assay

Jun 8, 2022

Quotient, Theradiag Announce Dx Partnership

May 26, 2022

QuantuMDx Obtains CE Mark for 30-Minute Multiplex Respiratory Panel

May 17, 2022

Immunovia Cleared to Offer Pancreatic Cancer Test in Rhode Island

May 12, 2022

SomaLogic Q1 Revenues Grow 22 Percent

Mar 9, 2022

Reveal Genomics Introduces HER2DX Breast Cancer Test in Europe, Plans US Expansion
Premium

Mar 8, 2022

Quotient Limited Nabs CE Mark for Immunohematology Microarray

Feb 2, 2022

Spain's ICN2 Awarded €161K to Develop Point-of-Care Test for Breast Cancer Diagnosis
Premium

Nov 22, 2021

PathogenDx, Axiology Labs Ink COVID Variant Test Distribution Deal for Africa, Thailand

Sep 28, 2021

Schott Minifab Acquires Applied Microarrays to Expand US Manufacturing Capabilities

Aug 25, 2021

Single-Molecule Microfluidic ELISA Platform Holds Promise for Rapid Bedside Diagnostics
Premium

Jul 21, 2021

PathogenDx Gets CE Mark for Microarray-Based COVID-19 Test

Jun 23, 2021

Infinity BiologiX to Offer Cytox Alzheimer's Disease Genetic Risk Test in US

May 13, 2021

Diacarta Positioning Liquid Biopsy Assay to Gauge Chemotherapy Response in Multiple Cancers
Premium

Apr 22, 2021

Immunovia Preparing to Launch Laboratory-Developed Test for Pancreatic Cancer
Premium

Feb 2, 2021

Visby Medical Wins $12.3M BARDA Contract for Coronavirus, Flu Combo Test

Feb 1, 2021

Quotient Limited Fiscal Q3 Revenues Rise 11 Percent

Dec 23, 2020

Agilent Receives Approval for Microarray-Based Postnatal Assay in Japan

Nov 18, 2020

Bioneer Gets CE-IVD Marks for Combination Coronavirus, Flu Assays

Nov 10, 2020

Zymo Research Gets CE-IVD Mark for SARS-CoV-2 Multiplex Kit